| Value | ₹0.01 Cr |
|---|---|
| Execution period | One month |
BSE filing, NSE: ACUTAAS. Summary written from the filing by ALFA Finder's alert engine.
Acutaas Chemicals Ltd: key numbers
- Share price
- ₹3,916.90
- Market cap
- ₹32,068 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 73.0×Sector 43.8×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 22.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acutaas Chemicals Ltd
All →Acutaas Chemicals Management Change
Acutaas Chemicals appointed Dr. Ashish Kumar Pandey as AVP Operations (Cluster Head, Units 2 & 3) and designated as SMP from November 2, 2026. Two existing GMs ceased to be SMP but continue in the company.
Acutaas Chemicals Earnings Call Transcript: Key Takeaways
Acutaas reports high-growth Q2 fueled by pharma intermediates and CDMO scaling, despite commodity chemical phase-outs.
- Call
- Guides 100% growth
Acutaas Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹4,369 Mn (+42.7% YoY), EBITDA ₹1,760 Mn (+84.6%, 40.3% margin), PAT ₹1,231 Mn (+71.4%). FY27 revenue guidance raised; South Korea semiconductor-chemicals facility inaugurated.
- Call
- Guides 30% growth
Acutaas Chemicals Results Update
Q2 FY27 revenue rose 42.7% YoY to ₹4,369 mn; PAT up 71.4% to ₹1,231 mn. Guidance raised to 30% revenue growth and 38-40% EBITDA margin.
Acutaas Chemicals Q2 FY27 Results: Net Profit ₹123.1 Cr, Up 71.2% YoY
Acutaas Chemicals Ltd reported revenue from operations of ₹436.9 Cr (+42.7% YoY) and net profit of ₹123.1 Cr (+71.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹123.1 Cr · +71.2% YoY
Acutaas Chemicals Financial Results
Acutaas Chemicals' board approved Q2 and half-year FY2027 unaudited results. The board meeting closed with no other material transaction disclosed.
Other acquisition announcements
All →GP Petroleums Acquisition Worth ₹44.27 Cr
GP Petroleums signed a share purchase agreement for a 22.45% stake in Incubit Pipavav Terminal, up to Rs.44.27 Crore. Payment is spread over one year in tranches.
- Value
- ₹44.27 Cr
- Execution
- One year, payable in one or more tranches
Cupid Acquisition Worth ₹137.9 Cr
Cupid Limited will acquire Baazar Style Retail Ltd for Rs. 137.87 Crore in cash, paid on exercise of warrant conversion into equity shares. The deal gives Cupid a retail channel to scale its FMCG portfolio.
- Value
- ₹137.9 Cr
- Execution
- As per timelines under SEBI (ICDR) Regulations, 2018
EIH Associated Hotels Acquisition Worth ₹0.46 Cr
EIH Associated Hotels will invest up to 26% in solar SPV Avaada Indsolar for up to Rs 0.46 crore. It secures renewable power for its hotels.
- Value
- ₹0.46 Cr
- Execution
- Completion by March 2027
- solar capacity
- 1.0 MWac
Alivus Life Sciences Acquisition
Alivus Life Sciences signed a Shareholders' Agreement with IQGEN-X Pharma and its continuing shareholders. It governs inter se rights after the company's 76% IQGEN-X stake purchase.
Warren Tea Acquisition
Warren Tea Limited disclosed that NCLT Kolkata sanctioned its amalgamation with Maple Hotels & Resorts Limited on 5 November 2026. The scheme takes effect once the certified order is filed with the Registrar of Companies.
Matrimony.com Acquisition Worth ₹8 Cr
Matrimony.com will acquire 50% additional control of Astro-Vision Futuretech for Rs 8 Crore cash. The deal, tranched over three months, raises its stake to about 76%.
- Value
- ₹8.00 Cr
- Execution
- 3 months